Montelukast Sodium Tablet, Chewable
Product Images NDC 68788-7669

5 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Montelukast Sodium (NDC 68788-7669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A line graph depicting change in height (cm) over weeks on treatment, comparing montelukast sodium chewable tablets 5 mg, beclomethasone 334 mcg, and placebo. The graph shows linear increases in height throughout the study period for each treatment group, with data points connected by lines and a legend identifying each group.*
FDA Label Image
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A line graph illustrating mean percent change from baseline over weeks in treatment for montelukast sodium compared to placebo. The x-axis represents weeks in treatment (0 to 15), and the y-axis shows percent change. Montelukast sodium shows a higher increase than placebo, with a washout period indicated after week 12.*
FDA Label Image

Montelukastsodium5mg30scount

Montelukastsodium5mg30scount
Montelukast Sodium Chewable Tablets 5 mg label from Preferred Pharmaceuticals, Inc. The label highlights the product as chewable tablets containing 5 mg montelukast sodium. It displays dosage instructions in English and Spanish, directions to take one tablet daily, and includes cautionary statements and barcodes. Manufacturer information is partially visible as Camber Pharmaceuticals, Inc., Piscataway, NJ.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of montelukast sodium, showing its molecular framework including the chlorophenyl, quinoline, benzene rings, and characteristic sulfonamide and carboxylate groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.